Tanya Durkee Urbach - 06 Sep 2022 Form 4 Insider Report for CytoDyn Inc. (CYDY)

Role: Director
Signature: /s/ Antonio Migliarese, Attorney-In-Fact
Issuer symbol: CYDY
Transactions as of: 06 Sep 2022
Net transactions value: $0
Form type: 4
Filing time: 08 Sep 2022, 21:48:45 UTC
Previous filing: 13 Dec 2021
Next filing: 05 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CYDY	Common Stock						162,113	06 Sep 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CYDY	Non-qualified stock option (right to buy)	Award	$0	+112,500		$0.000000	112,500	06 Sep 2022	Common Stock	112,500	$0.5000	Direct
transaction	CYDY	Non-qualified stock option (right to buy)	Award	$0	+247,111		$0.000000	241,111	06 Sep 2022	Common Stock	247,111	$0.5000	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	As of August 31, 2022, 61,777 shares have vested; the balance will vest in nine equal monthly installments beginning on September 1, 2022, subject to Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) through the applicable vesting date.